首页> 外文期刊>British Biotechnology Journal >Isolation and Identification of Actinomycetes from Mangrove Soil and Extraction of Secondary Metabolites for Antibacterial Activity
【24h】

Isolation and Identification of Actinomycetes from Mangrove Soil and Extraction of Secondary Metabolites for Antibacterial Activity

机译:从红树林土壤中分离和鉴定放线菌并提取具有抗菌活性的次生代谢产物

获取原文
           

摘要

The mangrove ecosystem of India is an extensively unexplored source for actinomycetes with the potential to produce secondary metabolites of biological importance. In this study, twenty two actinomycetes were isolated from different soil samples collected from the Bhitarkanika mangrove forest along Odisha coast, India. These isolates were identified as Streptomyces sp. based on their morphological, physiological and biochemical characteristics as described in the International Streptomyces Project . Out of twenty two actinomycetes (designated as BSA-1 to BSA-22) isolates, only four isolates (BSA-5, BSA-10, BSA-11 and BSA-15) displayed significant antimicrobial properties in term of antagonistic activity against six human pathogenic bacterial strains ( Staphylococcus aureus, Shigella flexneri, Bacillus licheniformis, Bacillus brevis, Pseudomonas aeruginosa and Escherichia coli ). All these isolates exhibited excellent antimicrobial activity in a range of 14.0-22.0 mm as inhibition zone against the above studied human pathogens with highest activity displayed by the isolate BSA-11. The isolate, Streptomyces sp. BSA-11 was further identified up to the species level by 16S rRNA gene sequence analysis. The BLAST analysis confirmed that Streptomyces sp. BSA-11 was homologous to Streptomyces himastatinicus of order Actinomycetles and class Actinobacteria . The novel actinomycete, Streptomyces himastatinicus BSA-11 from Bhitarkanika has the ability to produce extracellular potent bioactive compounds which can be a potential source of many antimicrobials.
机译:印度的红树林生态系统是放线菌的一个尚未被广泛开发的来源,可能产生具有生物学重要性的次生代谢产物。在这项研究中,从印度奥里萨邦沿岸的Bhitarkanika红树林中收集的不同土壤样品中分离出22种放线菌。这些分离物被鉴定为链霉菌。根据国际链霉菌项目中所述的形态,生理和生化特征。在二十二种放线菌(称为BSA-1至BSA-22)分离株中,只有四个分离株(BSA-5,BSA-10,BSA-11和BSA-15)在对六种人类的拮抗活性方面表现出显着的抗菌特性。致病细菌菌株(金黄色葡萄球菌,弗氏志贺氏菌,地衣芽孢杆菌,短芽孢杆菌,铜绿假单胞菌和大肠杆菌)。所有这些分离物在对上述研究的人类病原体的抑制带中均表现出极佳的抗菌活性,其抑制范围为14.0-22.0 mm,BSA-11表现出了最高的活性。分离株,链霉菌。通过16S rRNA基因序列分析进一步鉴定了BSA-11直至物种水平。 BLAST分析证实链霉菌属sp。 BSA-11与放线菌和放线菌类的链霉菌(Streptomyces himastatinicus)同源。来自Bhitarkanika的新型放线菌,heastatinicus BSA-11链霉菌具有产生细胞外有效生物活性化合物的能力,该化合物可能是许多抗微生物剂的潜在来源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号